Literature DB >> 2876022

T cell subsets and thyroid-stimulating antibodies in patients with Graves' disease in clinical remission.

M Bagnasco, E Macchia, G Ciprandi, M Caria, G F Fenzi.   

Abstract

Patients with active Graves' disease almost constantly show phenotypic alterations of T lymphocytes, such as an increase of "activated" cells recognized by various surface markers (e.g. la antigens). Such alterations are present in a certain number of apparently cured patients. The data herein reported refer to 25 patients with Graves' disease in clinical remission, in whom we have attempted to correlate T cell subset imbalances, the presence of thyroid-stimulating antibodies (TSAb) and the outcome of the subsequent relapse. The results obtained show a significant association between TSAb and the increase of la-positive T cells: no relationship was found between TSAb and other T lymphocyte subsets. One-year clinical follow-up of the patients enabled us to see relapses of hyperthyroidism in only two patients, who had shown in the first control both TSAb positivity and increased la-positive T cells. These results, in our opinion, suggest a role of la antigens expression on T lymphocytes in the clinical course of Graves' disease.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2876022     DOI: 10.1007/BF03348102

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  17 in total

1.  A PREPARATIVE METHOD FOR THE SEPARATION OF 7S GAMMA GLOBULIN FROM HUMAN SERUM.

Authors:  J S BAUMSTARK; R J LAFFIN; W A BARDAWIL
Journal:  Arch Biochem Biophys       Date:  1964-12       Impact factor: 4.013

2.  Radio-receptor assay of TSH: its use to detect thyroid-stimulating immunoglobulins.

Authors:  G Fenzi; E Macchia; L Bartalena; F Mazzanti; L Baschieri; L J DeGroot
Journal:  J Endocrinol Invest       Date:  1978-01       Impact factor: 4.256

3.  Why thyroid is major site of thyroid autoantibody synthesis in autoimmune thyroid disease.

Authors:  G W Canonica; M Bagnasco; M E Cosulich; G Torre; S M McLachlan; B R Smith
Journal:  Lancet       Date:  1983-05-21       Impact factor: 79.321

4.  T lymphocyte subpopulations in Graves' disease: relationship with clinical conditions.

Authors:  M Bagnasco; G W Canonica; S Ferrini; P Biassoni; G Melioli; O Ferrini; G Giordano
Journal:  Acta Endocrinol (Copenh)       Date:  1983-02

5.  Circulating T-cell subsets in Graves' disease: differences between patients with active disease and in remission after 131I-therapy.

Authors:  G W Canonica; M Bagnasco; S Ferrini; P Biassoni; G Giordano; G Corte
Journal:  Clin Immunol Immunopathol       Date:  1983-08

6.  Circulating T lymphocytes in Hashimoto's disease: imbalance of subsets and presence of activated cells.

Authors:  G W Canonica; M Bagnasco; G Corte; S Ferrini; O Ferrini; G Giordano
Journal:  Clin Immunol Immunopathol       Date:  1982-06

7.  Comparison between thyroid stimulating and tsh-binding inhibiting immunoglobulins of Graves' disease.

Authors:  E Macchia; G F Fenzi; F Monzani; F Lippi; P Vitti; L Grasso; L Bartalena; L Baschieri; A Pinchera
Journal:  Clin Endocrinol (Oxf)       Date:  1981-08       Impact factor: 3.478

8.  Human T cell subpopulations defined by a monoclonal antibody. I. A small subset is responsible for proliferation to allogeneic cells or to soluble antigens and for helper activity for B cell differentiation.

Authors:  G Corte; M C Mingari; A Moretta; G Damiani; L Moretta; A Bargellesi
Journal:  J Immunol       Date:  1982-01       Impact factor: 5.422

9.  Surface antigens specifically expressed by activated T cells in humans.

Authors:  G Corte; L Moretta; G Damiani; M C Mingari; A Bargellesi
Journal:  Eur J Immunol       Date:  1981-02       Impact factor: 5.532

10.  Autoimmune thyroiditis: a condition related to a decrease in T-suppressor cells.

Authors:  C Thielemans; L Vanhaelst; M de Waele; M Jonckheer; B Van Camp
Journal:  Clin Endocrinol (Oxf)       Date:  1981-09       Impact factor: 3.478

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.